OTC Pharmaceuticals in Asia-Pacific

Datamonitor's OTC Pharmaceuticals in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in Asia-Pacific’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in Asia-Pacific

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

[Studien Infos ausblenden]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 20
Rivalry 21
LEADING COMPANIES 22
Johnson & Johnson 22
Novartis AG 27
GlaxoSmithKline Plc 31
MARKET DISTRIBUTION 36
MARKET FORECASTS 37
Market value forecast 37
APPENDIX 38
Methodology 38
Industry associations 39
Related Datamonitor research 39
Disclaimer 41
ABOUT DATAMONITOR 42
Premium Reports 42
Summary Reports 42
Datamonitor consulting 42

LIST OF TABLES
Table 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Asia-Pacific OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Asia-Pacific OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Johnson & Johnson: key facts 22
Table 6: Johnson & Johnson: key financials ($) 24
Table 7: Johnson & Johnson: key financial ratios 25
Table 8: Novartis AG: key facts 27
Table 9: Novartis AG: key financials ($) 29
Table 10: Novartis AG: key financial ratios 29
Table 11: GlaxoSmithKline Plc: key facts 31
Table 12: GlaxoSmithKline Plc: key financials ($) 33
Table 13: GlaxoSmithKline Plc: key financials (£) 34
Table 14: GlaxoSmithKline Plc: key financial ratios 34
Table 15: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2009 36
Table 16: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2009–14 37

LIST OF FIGURES
Figure 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Asia-Pacific OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Asia-Pacific OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2009 20
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2009 21
Figure 11: Johnson & Johnson: revenues & profitability 25
Figure 12: Johnson & Johnson: assets & liabilities 26
Figure 13: Novartis AG: revenues & profitability 30
Figure 14: Novartis AG: assets & liabilities 30
Figure 15: GlaxoSmithKline Plc: revenues & profitability 35
Figure 16: GlaxoSmithKline Plc: assets & liabilities 35
Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2009 36
Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2009–14 37


[Inhaltsverzeichnis ausblenden]